Concepedia

Deborah Slipetz

DS

8

Publications

360

Citations

8

H-Index

2001

Active since

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

United States Military Academy

Deborah Slipetz is an author at Merck Canada Inc. (Canada) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2001–2017

8

Publications

8

Prostaglandin Receptor EP<sub>4</sub> Mediates the Bone Anabolic Effects of PGE<sub>2</sub>

M. Machwate, Satoru Harada, Chih‐Tai Leu et al. · Molecular Pharmacology · 2001 · 167 citations

Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist

Robert N. Young, Xavier Billot, Yongxin Han et al. · Heterocycles · 2004 · 53 citations · Full text

, , +16

Comparison between two classes of selective EP3 antagonists and their biological activities

Michel Belley, Chi Chung Chan, Yves Gareau et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 32 citations · Full text

, , +9

Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor

Fiona Elwood, David J. Witter, Jennifer Piesvaux et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 32 citations

Structure–activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP3 antagonists

Michel Belley, Michel Gallant, Bruno Roy et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 28 citations · Full text

, , +9

Rows per page

1–5 of 8